BioLineRx Ltd. (BLRX.TA)
ILA 5.8
(-9.38%)
ILA 5.8
(-9.38%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 11.59 Million USD | -5.95% |
| 2022 | 12.32 Million USD | 164.98% |
| 2021 | 4.65 Million USD | -39.47% |
| 2020 | 7.68 Million USD | -26.5% |
| 2019 | 10.45 Million USD | 19.72% |
| 2018 | 8.73 Million USD | 3393.2% |
| 2017 | 250 Thousand USD | -27.11% |
| 2016 | 343 Thousand USD | -21.51% |
| 2015 | 437 Thousand USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | -100.0% |
| 2012 | 36.67 Thousand USD | -66.53% |
| 2011 | 109.56 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 11.31 Million USD | -2.39% |
| 2024 Q2 | 31.25 Million USD | 176.25% |
| 2023 FY | 11.59 Million USD | -5.95% |
| 2023 Q2 | 13.53 Million USD | 5.11% |
| 2023 Q1 | 12.87 Million USD | 4.5% |
| 2023 Q3 | 13.31 Million USD | -1.65% |
| 2023 Q4 | 11.59 Million USD | -12.93% |
| 2022 Q1 | 3.7 Million USD | -20.28% |
| 2022 FY | 12.32 Million USD | 164.98% |
| 2022 Q4 | 12.32 Million USD | 13.97% |
| 2022 Q3 | 10.81 Million USD | 313.66% |
| 2022 Q2 | 2.61 Million USD | -29.5% |
| 2021 Q2 | 6.23 Million USD | -8.96% |
| 2021 Q1 | 6.84 Million USD | -10.87% |
| 2021 FY | 4.65 Million USD | -39.47% |
| 2021 Q4 | 4.65 Million USD | -14.22% |
| 2021 Q3 | 5.42 Million USD | -13.04% |
| 2020 Q3 | 8.32 Million USD | -7.78% |
| 2020 FY | 7.68 Million USD | -26.5% |
| 2020 Q1 | 9.68 Million USD | -7.33% |
| 2020 Q4 | 7.68 Million USD | -7.69% |
| 2020 Q2 | 9.02 Million USD | -6.84% |
| 2019 Q3 | 10.88 Million USD | 1.32% |
| 2019 Q2 | 10.74 Million USD | 0.55% |
| 2019 Q1 | 10.68 Million USD | 22.37% |
| 2019 FY | 10.45 Million USD | 19.72% |
| 2019 Q4 | 10.45 Million USD | -3.98% |
| 2018 Q3 | 179 Thousand USD | -11.39% |
| 2018 Q2 | 202 Thousand USD | -10.62% |
| 2018 Q1 | 226 Thousand USD | -9.6% |
| 2018 Q4 | 8.73 Million USD | 4778.77% |
| 2018 FY | 8.73 Million USD | 3393.2% |
| 2017 Q2 | 296 Thousand USD | -7.5% |
| 2017 Q4 | 250 Thousand USD | -8.42% |
| 2017 Q3 | 273 Thousand USD | -7.77% |
| 2017 Q1 | 320 Thousand USD | -6.71% |
| 2017 FY | 250 Thousand USD | -27.11% |
| 2016 Q2 | 389 Thousand USD | -5.81% |
| 2016 Q3 | 365 Thousand USD | -6.17% |
| 2016 Q4 | 343 Thousand USD | -6.03% |
| 2016 Q1 | 413 Thousand USD | -5.49% |
| 2016 FY | 343 Thousand USD | -21.51% |
| 2015 Q3 | 459 Thousand USD | 0.0% |
| 2015 Q4 | 437 Thousand USD | -4.79% |
| 2015 FY | 437 Thousand USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2013 Q1 | 14.77 Thousand USD | -59.7% |
| 2013 FY | - USD | -100.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | -100.0% |
| 2012 Q3 | 43.66 Thousand USD | -32.73% |
| 2012 FY | 36.67 Thousand USD | -66.53% |
| 2012 Q1 | 90.17 Thousand USD | -17.69% |
| 2012 Q2 | 64.9 Thousand USD | -28.02% |
| 2012 Q4 | 36.67 Thousand USD | -16.02% |
| 2011 Q3 | 132.98 Thousand USD | -21.36% |
| 2011 Q4 | 109.56 Thousand USD | -17.61% |
| 2011 FY | 109.56 Thousand USD | 0.0% |
| 2011 Q1 | 188.17 Thousand USD | 0.0% |
| 2011 Q2 | 169.1 Thousand USD | -10.14% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Matricelf Ltd | 1.24 Million ILA | -833.253% |